Turkiye Klinikleri Journal of Forensic Medicine and Forensic Sciences

.: REVIEW
Göz İçi Sıvısının Adli Tıp ve Adli Toksikolojideki Uygulamaları
Applications of Vitreous Humor in Forensic Medicine and Forensic Toxicology
Simge ZENGİNa, Selda MERCANa
aİstanbul Üniversitesi-Cerrahpaşa, Adli Tıp ve Adli Bilimler Enstitüsü, Fen Bilimleri ABD, İstanbul, TÜRKİYE
Turkiye Klinikleri J Foren Sci Leg Med. 2021;18(1):87-99
doi: 10.5336/forensic.2020-80443
Article Language: TR
Full Text
ÖZET
 Vitröz cisimciği olarak da bilinen göz içi sıvısı (GİS), %98-99'u su, protein, glikozaminoglikan, enzimler, metabolitler, hücreler, yağ asitleri ve elektrolitlerden oluşan jel formda bir sıvıdır. Bu biyolojik sıvı, postmortem araştırmalarda alternatif matriks olma özelliği taşımaktadır. Fiziksel, kimyasal ve biyolojik inertliği, otolize karşı dirençli olması, pütrifikasyon (çürüme) görülmemesi, postmortem yeniden dağılımın daha sınırlı olması, mikrobiyal üreme görülmemesi ve kontaminasyona karşı oldukça korunaklı olması, bu sıvıyı diğer postmortem biyolojik sıvılara göre avantajlı hâle getirmektedir. Bu nedenle postmortem evrede toplanması gereken ve antemortem dönem hakkında bilgi verebilecek değerli biyolojik materyaldir. GİS, adli bilimler alanına; postmortem ölüm zamanı tahmininde, ilaç/psikoaktif madde ve metabolit analizinde, antemortem alkol kullanımı (akut veya kronik) hakkında bilgi edinilmesinde, elektrolit bozuklukların tespitinde ve diyabetik ketoasidozun belirlenmesinde katkı sağlamaktadır. Özellikle ölüm esnasında herhangi bir şahidin bulunmadığı durumlarda ölüm nedenini ve zamanını belirleyebilir, olası şüpheli/şüphelileri dışlayabilir ve adli sürece katkılar sağlayabilir. Alternatif kullanım alanları üzerine hâlen sürdürülmekte olan araştırmalar son zamanlarda GİS'in, kişinin böbrek fonksiyonu hakkında da bilgi verebileceği üzerinde yoğunlaşmaktadır. Bu çalışmada, adli bilimler için önemli bir biyolojik örnek olan GİS'in, fiziksel ve kimyasal özelliklerinin, adli tıp ve adli toksikoloji alanlarındaki mevcut kullanımının, avantajlarının, kısıtlılıklarının ve potansiyel kullanım alanlarının ve analiz yöntemlerinin ele alınması amaçlanmıştır.

Anahtar Kelimeler: Göz içi sıvısı; postmortem; post-mortem interval; antemortem
ABSTRACT
 Vitreous humor, also known as vitreous body, is a fluidlike gel, composed of approximately 98-99% water with protein, glycosaminoglycan, enzymes, metabolites, cells, fatty acids and electrolytes. This biological fluid has the feature of being an alternative matrix in post-mortem investigations. Physical, chemical and biological inertness, resisting to autolysis and putrefaction, limited postmortem redistribution, no microbial reproduction, and protecting itself from contaminations are some specific properties of the vitreous humor. This specimen having several ante-mortem information has many advantages than other post-mortem biological fluids. Applications of this biological sample in forensic sciences are post-mortem interval (PMI) estimation, determination of drug/psychoactive substances and their metabolites, ante-mortem alcohol consumption (acute or chronic), electrolyte imbalance assessment and diabetic ketoacidosis evaluation. Based on the analysis of vitreous humor, cause of death and PMI could be detected especially in the case of the absence of witness during death, therefore it may eliminate suspects, and contributes forensic investigation. Ongoing research on possible uses is focused on that vitreous humor may also provide information about the person's kidney function at the ante-mortem condition. This alternative biological sample is a promising fluid in post-mortem researches and other uses areas of this fluid is still searching. In this study, it was aimed to handle vitreous humor's chemical and physical structure, current uses, advantages and limitations of using this matrix in the forensic sciences and forensic toxicology, and analysis methods as a promising biological sample in the forensic field.

Keywords: Vitreous humor; post-mortem; post-mortem interval; ante-mortem
REFERENCES:
  1. Kalra J, Mulla A, Kopargaonkar A. Diagnostic value of vitreous humor in postmortem analysis. SM J Clin Pathol. 2016;1(1):1005.[Link] 
  2. Baniak N, Campos-Baniak G, Mulla A, Kalra J. Vitreous humor: a short review on post-mortem applications. J Clin Exp Pathol 2015;5(1):1-7.[Link] 
  3. Bévalot F, Cartiser N, Bottinelli C, Fanton L, Guitton J. Vitreous humor analysis for the detection of xenobiotics in forensic toxicology: a review. Forensic Toxicol. 2016;34:12-40.[Crossref] [PubMed] [PMC] 
  4. Lappas NT, Lappas CM. Analytical samples. Forensic Toxicology: Principles and Concepts. 1st ed.Oxford: Elsevier; 2016. p.113-20.[Crossref] 
  5. Mathur A, Agrawal YK. An overview of methods used for estimation of time since death. Australian Journal of Forensic Sciences. 2011;43(4):275-85.[Crossref] 
  6. Kleinberg TT, Tzekov RT, Stein L, Ravi N, Kaushal S. Vitreous substitutes: a comprehensive review. Surv Ophthalmol. 2011;56(4):300-23.[Crossref] [PubMed] 
  7. Pigaiani N, Bertaso A, De Palo EF, Bortolotti F, Tagliaro F. Vitreous humor endogenous compounds analysis for post-mortem forensic investigation. Forensic Sci Int. 2020;310:110235.[Crossref] [PubMed] 
  8. Käsdorf BT, Arends F, Lieleg O. Diffusion regulation in the vitreous humor. Biophys J. 2015;109(10):2171-81.[Crossref] [PubMed] [PMC] 
  9. Donati S, Caprani SM, Airaghi G, Vinciguerra R, Bartalena L, Testa F, et al. Vitreous substitutes: the present and the future. Biomed Res Int. 2014;2014:351804.[Crossref] [PubMed] [PMC] 
  10. Gürler M, Altuntaş A. [Postmortem biochemistry]. Dicle Medical Journal. 2014;41(4):773-80.[Crossref] 
  11. Dinis-Oliveira RJ, Vieira DN, Magalhães T. Guidelines for Collection of Biological Samples for Clinical and Forensic Toxicological Analysis. Forensic Sci Res. 2017;1(1):42-51.[Crossref] [PubMed] [PMC] 
  12. Pelander A, Ristimaa J, Ojanperä I. Vitreous humor as an alternative matrix for comprehensive drug screening in postmortem toxicology by liquid chromatography-time-of-flight mass spectrometry. J Anal Toxicol. 2010;34(6):312-8.[Crossref] [PubMed] 
  13. Baduroğlu E, Durak D. [The forensic medicine problems related with alcohol]. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2010;36(2):65-71.[Link] 
  14. Kugelberg FC, Jones AW. Interpreting results of ethanol analysis in postmortem specimens: a review of the literature. Forensic Sci Int. 2007;165(1):10-29.[Crossref] [PubMed] 
  15. Ioan BG, Jitaru V, Damian R, Damian SI. Study on the relationship between the concentration of ethanol in the blood, urine and the vitreous humour. Rom J Leg Med. 2015;23(3):211-6.[Crossref] 
  16. Caplan YH, Levine B. Vitreous humor in the evaluation of postmortem blood ethanol concentrations. J Anal Toxicol. 1990;14(5):305-7.[Crossref] [PubMed] 
  17. Li W, Chang Y, Cheng Z, Ling J, Han L, Li X, et al. Vitreous humor: a review of biochemical constituents in postmortem interval estimation. Journal of Forensic Science and Medicine 2018;4(2):85-90.[Link] 
  18. Madea B, Henssge C, Hönig W, Gerbracht A. References for determining the time of death by potassium in vitreous humor. Forensic Sci Int. 1989;40(3):231-43.[Crossref] [PubMed] 
  19. Murthy AS, Das S, Thazhath HK, Chaudhari VA, Adole PS. The effect of cold chamber temperature on the cadaver's electrolyte changes in vitreous humor and plasma. J Forensic Leg Med. 2019;62:87-91.[Crossref] [PubMed] 
  20. Bray M. Chemical estimation of fresh water immersion intervals. Am J Forensic Med Pathol. 1985;6(2):133-9.[Crossref] [PubMed] 
  21. Go A, Shim G, Park J, Hwang J, Nam M, Jeong H, et al. Analysis of hypoxanthine and lactic acid levels in vitreous humor for the estimation of post-mortem interval (PMI) using LC-MS/MS. Forensic Sci Int. 2019;299:135-41.[Crossref] [PubMed] 
  22. Belsey SL, Flanagan RJ. Postmortem biochemistry: current applications. J Forensic Leg Med. 2016;41:49-57.[Crossref] [PubMed] 
  23. Zilg B, Bernard S, Alkass K, Berg S, Druid H. A new model for the estimation of time of death from vitreous potassium levels corrected for age and temperature. Forensic Sci Int. 2015;254:158-66.[Crossref] [PubMed] 
  24. Hanna PE, Bellamy JE, Donald A. Postmortem eyefluid analysis in dogs, cats and cattle as an estimate of antemortem serum chemistry profiles. Can J Vet Res. 1990;54(4):487-94.[PubMed] [PMC] 
  25. Palmiere C, Mangin P. Urea nitrogen, creatinine, and uric acid levels in postmortem serum, vitreous humor, and pericardial fluid. Int J Legal Med. 2015;129(2):301-5.[Crossref] [PubMed] 
  26. Patrick WJ, Logan RW. Free amino acid content of the vitreous humour in cot deaths. Arch Dis Child. 1988;63(6):660-2.[Crossref] [PubMed] [PMC] 
  27. Ansari N, Menon SK. Determination of time since death using vitreous humor tryptophan. J Forensic Sci. 2017;62(5):1351-6.[Crossref] [PubMed] 
  28. Lale A, Yıldırım MŞ, Akçan R, Balseven Odabaşı A, Tümer AR. [Postmortem interval estimation by vitreous fluid analysis from past to present]. J For Med. 2017;31(1):26-35.[Crossref] 
  29. Odriozola A, Riancho JA, de la Vega R, Agudo G, García-Blanco A, de Cos E, et al. miRNA analysis in vitreous humor to determine the time of death: a proof-of-concept pilot study. Int J Legal Med. 2013;127(3):573-8.[Crossref] [PubMed] 
  30. Ojänpera I, Ojansivu RL, Nokua J, Vuori E. Comprehensive TLC drug screening in forensic toxicology: comparison of findings in urine and liver. J Planar Chromatogr-Mod TLC. 1999;12(1):38-41.[Link] 
  31. Busardò FP, Vaiano F, Mannocchi G, Bertol E, Zaami S, Marinelli E. Twelve months monitoring of hair GHB decay following a single dose administration in a case of facilitated sexual assault. Drug Test Anal. 2017;9(6):953-6.[Crossref] [PubMed] 
  32. Busardò FP, Portelli F, Montana A, Rotolo MC, Pichini S, Maresi E. When a death apparently associated to sexual assault is instead a natural death due to idiopathic hypereosinophilic syndrome: The importance of gamma-hydroxybutyric acid analysis in vitreous humor. Leg Med (Tokyo). 2017;26:92-97.[Crossref] [PubMed] 
  33. Pragst F, Spiegel K, Leuschner U, Hager A. Detection of 6-acetylmorphine in vitreous humor and cerebrospinal fluid--comparison with urinary analysis for proving heroin administration in opiate fatalities. J Anal Toxicol. 1999;23(3):168-72.[Crossref] [PubMed] 
  34. Robertson MD, Drummer OH. Postmortem distribution and redistribution of nitrobenzodiazepines in man. J Forensic Sci. 1998;43(1):9-13.[Crossref] [PubMed] 
  35. Scott KS, Oliver JS. The use of vitreous humor as an alternative to whole blood for the analysis of benzodiazepines. J Forensic Sci. 2001;46(3):694-7.[Crossref] [PubMed] 
  36. Antonides HM, Kiely ER, Marinetti LJ. Vitreous fluid quantification of opiates, cocaine, and benzoylecgonine: comparison of calibration curves in both blood and vitreous matrices with corresponding concentrations in blood. J Anal Toxicol. 2007;31(8):469-76.[Crossref] [PubMed] 
  37. Jenkins AJ, Oblock J. Phencyclidine and cannabinoids in vitreous humor. Leg Med (Tokyo). 2008;10(4):201-3.[Crossref] [PubMed] 
  38. De Letter EA, De Paepe P, Clauwaert KM, Belpaire FM, Lambert WE, Van Bocxlaer JF, et al. Is vitreous humour useful for the interpretation of 3,4-methylenedioxymethamphetamine (MDMA) blood levels? Experimental approach with rabbits. Int J Legal Med. 2000;114(1-2):29-35.[Crossref] [PubMed] 
  39. Holmgren P, Druid H, Holmgren A, Ahlner J. Stability of drugs in stored postmortem femoral blood and vitreous humor. J Forensic Sci. 2004;49(4):820-5.[Crossref] [PubMed] 
  40. Chesser R, Pardi J, Concheiro M, Cooper G. Distribution of synthetic opioids in postmortem blood, vitreous humor and brain. Forensic Sci Int. 2019;305:109999.[Crossref] [PubMed] 
  41. Palmiere C, Mangin P. Postmortem biochemical investigations in hypothermia fatalities. Int J Legal Med. 2013;127(2):267-76.[Crossref] [PubMed] 
  42. Iten PX, Meier M. Beta-hydroxybutyric acid--an indicator for an alcoholic ketoacidosis as cause of death in deceased alcohol abusers. J Forensic Sci. 2000;45(3):624-32.[Crossref] [PubMed] 
  43. Karlovsek MZ. Diagnostic values of combined glucose and lactate values in cerebrospinal fluid and vitreous humour--our experiences. Forensic Sci Int. 2004;146 Suppl:S19-23.[Crossref] [PubMed] 
  44. Osuna E, García-Víllora A, Pérez-Cárceles M, Conejero J, Maria Abenza J, Martínez P, et al. Glucose and lactate in vitreous humor compared with the determination of fructosamine for the postmortem diagnosis of diabetes mellitus. Am J Forensic Med Pathol. 2001;22(3):244-9.[Crossref] [PubMed] 
  45. Bray M, Luke JL, Blackbourne BD. Vitreous humor chemistry in deaths associated with rapid chilling and prolonged freshwater immersion. J Forensic Sci. 1983;28(3):588-93.[Crossref] [PubMed] 
  46. Coe JI. Hypothermia: autopsy findings and vitreous glucose. J Forensic Sci. 1984;29(2):389-95.[Crossref] [PubMed] 
  47. Fernández P, Seoane S, Vázquez C, Bermejo AM, Carro AM, Lorenzo RA. A rapid analytical method based on microwave-assisted extraction for the determination of drugs of abuse in vitreous humor. Anal Bioanal Chem. 2011;401(7):2177-86.[Crossref] [PubMed] 
  48. Nielsen SS. Immunoassays. Food Analysis. 5th ed. West Lafayette: Springer; 2017. p.188,488.
  49. Metushi IG, Fitzgerald RL, McIntyre IM. Assessment and comparison of vitreous humor as an alternative matrix for forensic toxicology screening by GC-MS. J Anal Toxicol. 2016;40(4):243-7.[Crossref] [PubMed] 
  50. Peres MD, Pelição FS, Caleffi B, De Martinis BS. Simultaneous quantification of cocaine, amphetamines, opiates and cannabinoids in vitreous humor. J Anal Toxicol. 2014;38(1):39-45.[Crossref] [PubMed] 
  51. Cabarcos P, Tabernero MJ, Álvarez I, López P, Fernández P, Bermejo AM. Analysis of six benzodiazepines in vitreous humor by high-performance liquid chromatography-photodiode-array detection. J Anal Toxicol. 2010;34(9):539-42.[Crossref] [PubMed] 
  52. Maurer HH. Liquid chromatography-mass spectrometry in forensic and clinical toxicology. J Chromatogr B Biomed Sci Appl. 1998;713(1):3-25.[Crossref] [PubMed] 
  53. Thierauf A, Kempf J, Perdekamp MG, Auwärter V, Gnann H, Wohlfarth A, et al. Ethyl sulphate and ethyl glucuronide in vitreous humor as postmortem evidence marker for ethanol consumption prior to death. Forensic Sci Int. 2011;210(1-3):63-8.[Crossref] [PubMed] 
  54. Fucci N, De Giovanni N, De Giorgio F, Liddi R, Chiarotti M. An evaluation of the Cozart RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor. Forensic Sci Int. 2006;156(2-3):102-5.[Crossref] [PubMed] 
  55. Ojanperä I, Vuori E, Nieminen R, Penttilä A. Screening for barbiturates in vitreous humor by the EMIT-st serum enzyme immunoassay. J Forensic Sci. 1986;31(2):707-9.[Crossref] [PubMed] 
  56. Chronister CW, Gund AL, Goldberger BA. Rapid detection of opioids in vitreous humor by enzyme immunoassay. J Anal Toxicol. 2008;32(8):601-4.[Crossref] [PubMed] 
  57. Mali N, Karpe M, Kadam V. A review on biological matrices and analytical methods used for determination of drug of abuse. Journal of Applied Pharmaceutical Science. 2011;1(6):58-65.[Link] 
  58. Kapur BM. False positive drugs of abuse immunoassays. Clin Biochem. 2012;45(9):603-4.[Crossref] [PubMed] 
  59. Datta P. Oxaprozin and 5-(p-hydroxyphenyl)-5-phenylhydantoin interference in phenytoin immunoassays. Clin Chem. 1997;43(8 Pt 1):1468-9.[Crossref] [PubMed] 
  60. Grinstead GF. Ranitidine and high concentrations of phenylpropanolamine cross react in the EMIT monoclonal amphetamine/methamphetamine assay. Clin Chem. 1989;35(9):1998-9.[Crossref] [PubMed] 
  61. Brahm NC, Yeager LL, Fox MD, Farmer KC, Palmer TA. Commonly prescribed medications and potential false-positive urine drug screens. Am J Health Syst Pharm. 2010;67(16):1344-50.[Crossref] [PubMed] 
  62. Randviir EP, Banks CE. Analytical methods for quantifying creatinine within biological media. Sensors and Actuators B: Chemical. 2013;183:239-52.[Crossref] 
  63. Santos Júnior JC, Mollo Filho PC, Felice Guidugli RB, Eberlin MN, Pessôa Gde S, da Silva EG, et al. Metals and (metallo)proteins identification in vitreous humor focusing on post-mortem biochemistry. Metallomics. 2014;6(10):1801-7.[Crossref] [PubMed] 
  64. Thierauf A, Musshoff F, Madea B. Post-mortem biochemical investigations of vitreous humor. Forensic Sci Int. 2009;192(1-3):78-82.[Crossref] [PubMed] 
  65. Costa JL, Morrone AR, Resende RR, Chasin AA, Tavares MF. Development of a method for the analysis of drugs of abuse in vitreous humor by capillary electrophoresis with diode array detection (CE-DAD). J Chromatogr B Analyt Technol Biomed Life Sci. 2014;945-946:84-91.[Crossref] [PubMed] 
  66. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-47.[Crossref] [PubMed] 
  67. Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis. 2013;62(2):245-52.[Crossref] [PubMed] [PMC] 
  68. Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58-66.[Crossref] [PubMed] 
  69. Lentini P, Zanoli L, Granata A, Signorelli SS, Castellino P, Dell'Aquila R. Kidney and heavy metals - The role of environmental exposure (Review). Mol Med Rep. 2017;15(5):3413-9.[Crossref] [PubMed] 
  70. Lea-Henry TN, Carland JE, Stocker SL, Sevastos J, Roberts DM. Clinical pharmacokinetics in kidney disease: fundamental principles. Clin J Am Soc Nephrol. 2018;13(7):1085-95.[Crossref] [PubMed] [PMC] 
  71. Kim SY, Moon A. Drug-induced nephrotoxicity and its biomarkers. Biomol Ther (Seoul). 2012;20(3):268-72.[Crossref] [PubMed] [PMC] 
  72. Sarwar A. Drugs in renal disease and pregnancy. Best Pract Res Clin Obstet Gynaecol. 2019;57:106-19.[Crossref] [PubMed] 
  73. Maskell PD, Penney E, Smith PR, Hikin LJ, Morley SR. Post-mortem diagnosis of kidney impairment: An experimental study. Forensic Sci Int. 2019;301:271-7.[Crossref] [PubMed] 
  74. Géhl Z, Bakondi E, Resch MD, Hegedűs C, Kovács K, Lakatos P, et al. Diabetes-induced oxidative stress in the vitreous humor. Redox Biol. 2016;9:100-3.[Crossref] [PubMed] [PMC] 
  75. Kumagai A, Nakayashiki N, Aoki Y. Analysis of age-related carbonylation of human vitreous humor proteins as a tool for forensic diagnosis. Leg Med (Tokyo). 2007;9(4):175-80.[Crossref] [PubMed] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com